This measure shows the proportion of females aged 50–74 years screened through BreastScreen Australia in a rolling 2-year period. Data for females aged 50–69 years (previous target age range) are also shown.
Numerator: Number of females in the target age range having received a mammogram through the national screening program over a 24-month period.
Denominator: Average number of female residents in the target age range during the 2-year reporting period.
Methodology:
Rates are age-standardised unless otherwise specified.
Note that participation is measured over 2 years to align with the 2-year recommended screening interval, as most females will only screen once within a 2-year period. A consequence of measuring participation over 2 years on an annual basis is that there are ‘rolling’ participation rates, in which there is an overlap of 1 calendar year between any 2 consecutive rates.
Caveats:
The program only includes asymptomatic females aged 50–74 years.
Caution should be applied to international comparisons as it is not known to what extent mammography outside of the organised screening programs will affect the participation rate for each country. Chile includes data from outside the organised screening program.
Remoteness
The Australian Statistical Geography Standard (ASGS) for 2011 was used to allocate participants to a remoteness area based on their area of usual residence.
Socioeconomic status (SES)
The Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) for 2011 was used to allocate participants to a SES quintile based on their usual residence.
Other data quality issues:
For the international comparison, the OECD indicator definition is: ‘the number of females aged 50–69 who have received a bilateral mammography within the past two years (or according to the specific screening frequency recommended in each country) divided by the number of females aged 50–69 eligible for an organised screening programme’.
The most recent year for data available by country is as follows:
Finland
|
2017
|
Denmark
|
2016
|
Netherlands
|
2015
|
Ireland
|
2017
|
United Kingdom
|
2018
|
Norway
|
2017
|
New Zealand
|
2018
|
Korea
|
2017
|
Australia
|
2016
|
Germany
|
2016
|
France
|
2017
|
Chile
|
2016
|
- Data sourced from OECD.Stat
- Rates are not age-standardised.
- Some countries have different target age ranges: Chile and Ireland (aged 50–64 years); United Kingdom (includes those aged 53–69 years for England, and aged 53–70 years for Wales and Northern Ireland).
- Different methodology was used for Ireland
- Rates for Finland and the Netherlands were estimated rates
- Data for Denmark apply to 2 of 5 regions and for the United Kingdom to 3 of 4 countries.
Data sources
Australian Institute of Health and Welfare 2019. BreastScreen Australia monitoring report 2019. Cancer series no. 127. Cat. no. CAN 128. Canberra: AIHW.
Australian Institute of Health and Welfare 2018. BreastScreen Australia monitoring report 2018. Cancer series no. 112. Cat. no. CAN 116. Canberra: AIHW
Australian Institute of Health and Welfare 2017. BreastScreen Australia monitoring report 2014–2015. Cancer series no. 106. Cat. no. CAN 105. Canberra: AIHW
Australian Institute of Health and Welfare 2016. BreastScreen Australia monitoring report 2013–2014. Cancer series no. 100. Cat. no. CAN 99. Canberra: AIHW
Australian Institute of Health and Welfare 2015. BreastScreen Australia monitoring report 2012–2013. Cancer series no.95. Cat. no. CAN 93. Canberra: AIHW